Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYC.
Siokatas C, Lampropoulou A, Smina A, Soupsana K, Kontostathi M, Karra AV, Karampelas T, Politou AS, Christoforidis S, Tamvakopoulos C, Sarli V.
Siokatas C, et al. Among authors: lampropoulou a.
ACS Pharmacol Transl Sci. 2024 Nov 15;7(12):3955-3968. doi: 10.1021/acsptsci.4c00452. eCollection 2024 Dec 13.
ACS Pharmacol Transl Sci. 2024.
PMID: 39698270